André Silva de Sousa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
André Silva de Sousa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bianca de Almeida-Pititto
Department of Preventive Medicine, Universidade Federal de São Paulo, São Paulo, BRA
2 shared publications - Claubert Radamés Oliveira Coutinho-Lima
Universidade do Estado da Bahia
2 shared publications - Edilene Maria Queiroz Araújo
Postgraduate Program in Evidence Based Medicine, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, SP, Brazil
2 shared publications - Graziela De Luca Canto
Postgraduate Program in Evidence‐Based Health, Escola Paulista de Medicina Federal University of São Paulo São Paulo São Paulo Brazil
2 shared publications - Helton Estrela Ramos
Departamento de Biorregulação, Instituto de Saúde e Ciências, Universidade Federal da Bahia, Salvador, BA, Brasil
2 shared publications - Lana Mércia Santiago de Souza
Nutritional Genomics and Metabolic Dysfunctions Research and Extension Center (GENUT), Department of Life Sciences, State University of Bahia (UNEB), Salvador 41.150-000, BA, Brazil
2 shared publications
Latest Publications
- Open Access
Effects of Gluten-Free Diet in Non-Celiac Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis
Background/Objectives: The gluten-free diet (GFD) may be anti-inflammatory in treating Hashimoto’s thyroiditis (HT), but the studies are inconsistent. Methods: To determine the effects of the GFD in non-celiac HT, we included randomized controlled trials from the following databases: Cochrane Central, Embase, Lilacs, Medline, Scopus, and Web of Science. The study was registered at Prospero (no. CRD42024566034). The outcomes assessed included free triiodothyronine (fT3), free tetraiodothyronine (fT4), thyroid stimulating hormone (TSH), Anti-thyroid Peroxidase (TPO), anti-thyroglobulin (Tg), C-reactive protein (CRP), body weight (BW), body mass index (BMI) and adverse effects. Sensitivity, subgroup, meta-regression, bias risk, and evidence analyses’ certainty were also assessed. Results: Only three studies were meta-analyzed, comprising 110 participants. The pooled data revealed the evidence was very uncertain about the effect of GFD compared to the control group on mean differences (MD) of TSH (MD −0.63 uIU/mL; 95% CI −1.63 to 0.36; p = 0.21), fT3 (MD −0.18 pg/mL; 95% CI −0.50 to 0.14; p = 0.28), fT4 (MD −0.33 ng/dL; 95% CI −0.89 to 0.23; p = 0.24), anti-Tg (MD −10.07 IU/mL; 95% CI −17.73 to −2.42; p = 0.010), anti-TPO (MD 76.19 IU/mL; 95% CI 46.86 to 108.51; p < 0.00001), CRP (MD −0.12 IU/mL; 95% CI −0.30 to 0.07), BW (MD −1.46 kg; 95% CI −6.70 to 3.77), and BMI (MD −1.80 kg/m2; 95% CI −3.30 to −0.31). The quality of evidence was rated as having serious methodological concerns to extremely serious imprecision. Conclusions: The GFD decreased anti-Tg and increased the anti-TPO levels, both significantly. There were no significant results on fT3, fT4, and TSH.
Open AccessEffects of Gluten-Free Diet in Non-Celiac Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis
Background/Objectives: The gluten-free diet (GFD) may be anti-inflammatory in treating Hashimoto’s thyroiditis (HT), but the studies are inconsistent. Methods: To determine the effects of the GFD in non-celiac HT, we included randomized controlled trials from the following databases: Cochrane Central, Embase, Lilacs, Medline, Scopus, and Web of Science. The study was registered at Prospero (no. CRD42024566034). The outcomes assessed included free triiodothyronine (fT3), free tetraiodothyronine (fT4), thyroid stimulating hormone (TSH), Anti-thyroid Peroxidase (TPO), anti-thyroglobulin (Tg), C-reactive protein (CRP), body weight (BW), body mass index (BMI) and adverse effects. Sensitivity, subgroup, meta-regression, bias risk, and evidence analyses’ certainty were also assessed. Results: Only three studies were meta-analyzed, comprising 110 participants. The pooled data revealed the evidence was very uncertain about the effect of GFD compared to the control group on mean differences (MD) of TSH (MD −0.63 uIU/mL; 95% CI −1.63 to 0.36; p = 0.21), fT3 (MD −0.18 pg/mL; 95% CI −0.50 to 0.14; p = 0.28), fT4 (MD −0.33 ng/dL; 95% CI −0.89 to 0.23; p = 0.24), anti-Tg (MD −10.07 IU/mL; 95% CI −17.73 to −2.42; p = 0.010), anti-TPO (MD 76.19 IU/mL; 95% CI 46.86 to 108.51; p < 0.00001), CRP (MD −0.12 IU/mL; 95% CI −0.30 to 0.07), BW (MD −1.46 kg; 95% CI −6.70 to 3.77), and BMI (MD −1.80 kg/m2; 95% CI −3.30 to −0.31). The quality of evidence was rated as having serious methodological concerns to extremely serious imprecision. Conclusions: The GFD decreased anti-Tg and increased the anti-TPO levels, both significantly. There were no significant results on fT3, fT4, and TSH.
- Open Access
- 26 June 2025
- Published by MDPI AG in Preprints.org
Effects of Gluten-Free Diet in Non-Celiac Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis
Background/Objectives: The gluten-free diet (GFD) may be anti-inflammatory in treating Hashimoto's thyroiditis (HT), but the studies are inconsistent. To determine the effects of the GFD in non-celiac HT. Methods: We included randomized controlled trials from the following databases: Cochrane Central, Embase, Lilacs, Medline, Scopus, and Web of Science. It was registered at Prospero (no. CRD42024566034). The outcomes assessed included free triiodothyronine (fT3), free tetraiodothyronine (fT4), Thyroid stimulating hormone (TSH), Anti-thyroid Peroxidase (TPO), anti-thyroglobulin (Tg), C-reactive protein (CRP), body weight (BW), body mass index (BMI) and adverse effects. Sensitivity, subgroup, meta-regression, bias risk, and evidence analyses' certainty were also conducted. Results: Only three studies were meta-analyzed, comprising 110 participants. The pooled data revealed the evidence was very uncertain about the effect of GFD compared to the control group on mean differences (MD) of: TSH (MD -0.63 uIU/mL; 95% CI -1.63 to 0.36; p= 0.21), fT3 (MD -0.18 pg/mL; 95% CI -0.50 to 0.14; p= 0.28), fT4(MD -0.33 ng/dL; 95% CI -0.89 to 0.23; p= 0.24), anti-Tg (MD -10.07 IU/mL; 95% CI -17.73 to -2.42; p= 0.010), anti-TPO (MD 76.19 IU/mL; 95% CI 46.86 to 108.51; p< 0.00001), CRP (MD -0.12 IU/mL; 95% CI -0.30 to 0.07), BW (MD -1.46 kg; 95% CI -6.70 to 3.77), BMI (MD -1.80 kg/m2; 95% CI -3.30 to -0.31). The quality of evidence was rated as serious methodological concerns to extremely serious imprecision. Conclusion: The GFD decreased Anti-Tg and increased the Anti-TPO levels, both significantly. There were no significant results on fT3, fT4, and TSH.
- 26 June 2025
- Published by MDPI AG in Preprints.org
Open AccessEffects of Gluten-Free Diet in Non-Celiac Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis
Background/Objectives: The gluten-free diet (GFD) may be anti-inflammatory in treating Hashimoto's thyroiditis (HT), but the studies are inconsistent. To determine the effects of the GFD in non-celiac HT. Methods: We included randomized controlled trials from the following databases: Cochrane Central, Embase, Lilacs, Medline, Scopus, and Web of Science. It was registered at Prospero (no. CRD42024566034). The outcomes assessed included free triiodothyronine (fT3), free tetraiodothyronine (fT4), Thyroid stimulating hormone (TSH), Anti-thyroid Peroxidase (TPO), anti-thyroglobulin (Tg), C-reactive protein (CRP), body weight (BW), body mass index (BMI) and adverse effects. Sensitivity, subgroup, meta-regression, bias risk, and evidence analyses' certainty were also conducted. Results: Only three studies were meta-analyzed, comprising 110 participants. The pooled data revealed the evidence was very uncertain about the effect of GFD compared to the control group on mean differences (MD) of: TSH (MD -0.63 uIU/mL; 95% CI -1.63 to 0.36; p= 0.21), fT3 (MD -0.18 pg/mL; 95% CI -0.50 to 0.14; p= 0.28), fT4(MD -0.33 ng/dL; 95% CI -0.89 to 0.23; p= 0.24), anti-Tg (MD -10.07 IU/mL; 95% CI -17.73 to -2.42; p= 0.010), anti-TPO (MD 76.19 IU/mL; 95% CI 46.86 to 108.51; p< 0.00001), CRP (MD -0.12 IU/mL; 95% CI -0.30 to 0.07), BW (MD -1.46 kg; 95% CI -6.70 to 3.77), BMI (MD -1.80 kg/m2; 95% CI -3.30 to -0.31). The quality of evidence was rated as serious methodological concerns to extremely serious imprecision. Conclusion: The GFD decreased Anti-Tg and increased the Anti-TPO levels, both significantly. There were no significant results on fT3, fT4, and TSH.